Correlation Between Altamira Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Altamira Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Altamira Therapeutics and Transcode Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Altamira and Transcode is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Altamira Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Altamira Therapeutics is expected to generate 0.86 times more return on investment than Transcode Therapeutics. However, Altamira Therapeutics is 1.16 times less risky than Transcode Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 11,480 in Altamira Therapeutics on August 26, 2024 and sell it today you would lose (11,438) from holding Altamira Therapeutics or give up 99.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Altamira Therapeutics vs. Transcode Therapeutics
Performance |
| Timeline |
| Altamira Therapeutics |
| Transcode Therapeutics |
Altamira Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Altamira Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Altamira Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |